Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference18 articles.
1. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer;Vokes;Semin Oncol,2000
2. Raltitrexed: current clinical status and future directions;Van Cutsem;Ann Oncol,2002
3. Preoperative chemoradiation with raltitrexed (Tomudex) for T2/N+ and T3/N+ rectal cancers: a phase I study;Valentini;Eur J Cancer,2001
4. Raltitrexed (tomudex) and radiotherapy can be combined as postoperative treatment for rectal cancer;Botwood;Ann Oncol,2000
5. Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study;James;Ann Oncol,2003
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis;BMC Cancer;2023-03-04
2. Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways;OncoTargets and Therapy;2020-12
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways
3. Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal carcinoma;Chinese Journal of Cancer Research;2020
4. The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study;Cancer Management and Research;2019-12
The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study
5. Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells;Cancer Cell International;2019-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3